ACSM becomes APSM

15th NOVEMBER 2011
The ACSM has changed its name to the Association of Pharmaceutical Specials Manufacturers (APSM) to reflect the clinical nature of its members’ products and services.
As the trade association representing the interests of companies involved in the manufacture of unlicensed medicines, the role and importance of the APSM has grown in recent months as the organisation has provided a conduit for information and advice to the DH in the lead up to the Specials Tariff (published this month).  
Specials account for around 1% of the prescription budget but this can be made up of more than 75,000 different formulations – each designed to meet the specific need of a patient where a licensed medicine is not available. 
Said APSM Chairman, Alan Krol, “Specials serve a vital clinical need, it really is tailored and personalised medicine in every way – no other pharmaceutical manufacturer gets closer to the patient.”
Said APSM Vice Chair, Sharon Griffiths, “Heightened interest in the Specials Tariff has revealed a general lack of knowledge about specials, at every level – including the specialist nature of manufacture.   We are part of the pharmaceutical industry and felt we needed to incorporate this into our name, and also into our descriptor ‘bespoke medicines for special clinical need”.
The APSM represents 16 companies who account for around 80% of commercially produced specials in the UK.   Collectively, these companies have invested more than £150million in innovation and define their role as ensuring the integrity and future of specials in a sector that serves the best interests of the patient.
Members all hold MS specials licence as well as signing up to a code of conduct that mandates various aspects of best practice, such as quality systems, staff training, customer advice lines and labelling and documentation.
For more information visit www.apsm-uk.com

PR CONTACT:  Lyn Wallace / lyn@wallacehcl.com / 020 8995 5354 or 07734 101024

Comments

Post a Comment

Popular posts from this blog

The Specials Tariff is important to ensure confidence and best practice within the sector

In response to an article in The Daily Telegraph June 22 nd , the APSM, Association of Pharmaceutical Specials Manufacturers, has spoken out in support of the Specials Tariff, a system that was introduced by the DOH to create a more transparent process for reimbursing specials, linking the cost of reimbursement to the cost of the product, while providing value for money for the NHS.  Since the introduction of the Specials Tariff in November 2011, the average cost per item has fallen by 25% (from £180 to £135).   The Specials Tariff was set using a system similar to that used for the calculation of the price of category M generics.  Under a memorandum of understanding (MOU), licensed specials manufacturers provided sales information to the DOH, which has been used to set a reimbursement price that includes margin.     These prices take into the account the high quality manufacturing processes that must be adhered to by companies wishing to supply products listed on the Specials
Read more

Specials record another year of delivering increased value to the NHS

The Specials Market in primary care was just over £ 80.5 million for the 12 month period Oct 15 - Sep 16.  Although the market continues to decline year-on-year, it is now stabilising following a period of readjustment in the wake of the Specials Tariff in November 2011.  During this time the mean cost per item has reduced from £180 per item before the tariff in Nov 2011, to an average £116 for the same 12 month period to Sep 2016. Whilst this represents value for money to the NHS, at the same time the high standards of quality involved in Specials manufacture have needed to be maintained.  According to the Association of Pharmaceutical Specials Manufacturers, APSM, members report continued investment in infrastructure and quality processes to meet the increasing regulatory demands required by the sector. To reflect the increased complexity of the market, l ast year (2016), the Association of Pharmaceutical Specials Manufacturers, APSM, decided to broaden its membership criter
Read more

APSM expands membership to reflect changing role of specials industry

The Association of Pharmaceutical Specials Manufacturers, APSM, has broadened its membership criteria to include importers as well as virtual Specials manufacturing organisations who own the rights to, and act as the first supplier of, a Specials medicine in the UK. Originally founded to represent the interests of holders of a Specials Manufacturing Licence, the APSM has an important role liaising with the DH and key policy makers as well as inputting into decisions around new legislation and Specials guidance. The decision to broaden membership to the wider supply chain reflects the changing shape of the Specials market, particularly over the last 5 years following the introduction of the Specials Tariff alongside a developing regulatory framework and professional guidance around Specials.  Influencing and responding to issues in this changing market has also become a more important role for the APSM. APSM Chair, Sharon Griffiths, said, “The decisions and actions we take now h
Read more